Organized by the SNMMI Clinical Trials Network
Speaker: David W. Dick, PhD
Date: May 7, 2020 at 3:00 pm ET
NDAs for new imaging agents, submitted by universities, have been approved recently and the universities have waived exclusivity rights. Would you like to use these new agents at your site? Learn the regulatory mechanisms that can be used (IND, ANDA, cost recovery, expanded access) to make these agents available to your patients. Have your staff – including your regulatory manager – register for this informative and helpful webinar.